Tramadol Hydrocoride - FDA

Is a drug marketed by Sun Pharm Inds, Macleods Pharms , Lupin , Amneal Pharms, Zydus Pharms Usa Inc, Sun Pharma Global, Actavis Elizabeth, Aurobindo Pharma , Northstar thcare, Mylan Pharms Inc, Watson Labs, Ivax Sub Teva Pharms, Sun Pharm Inds Inc, Sandoz, Ipca Labs , Asta, Aci Healthcare , Teva, Apotex, Pliva, Par Pharm Inc, Mallinckrodt, Mylan, Accord thcare Inc, Anchen Pharms, Cspc Ouyi Pharm Co, Micro Labs India, Par Pharm, Atlas Pharms Llc, and Apotex Inc. There are sixty-five drug master file entries for this compound.

Tramadol hydrocoride generic entry, patent expiration information.

There is disclosed a composition for oral administration of O-desmethyltramadol.

Tramadol Hydrocoride - FDA

Tramadol hydrocoride generic drug entry, pharmaceutical patent.

Is the generic ingredient in six branded drugs marketed by Sun Pharm Inds, Macleods Pharms , Lupin , Amneal Pharms, Zydus Pharms Usa Inc, Sun Pharma Global, Actavis Elizabeth, Aurobindo Pharma , Northstar thcare, Purdue Pharma, Mylan Pharms Inc, Watson Labs, Ivax Sub Teva Pharms, Sun Pharm Inds Inc, Sandoz, Cipher Pharms Inc, Ipca Labs , Asta, Aci Healthcare , Teva, Apotex, Janssen Pharms, Pliva, Par Pharm Inc, Mallinckrodt, Mylan, Accord thcare Inc, Anchen Pharms, Valeant Pharms, Shionogi Inc, and Cspc Ouyi Pharm Co, and is included in thirty-five NDAs.

Fed. Circ. Deems Purdue's Tramadol Patents Invalid - Law360

Since 2002, Michael and Shelly Mc Clendon have worked to become one of the premiere IT outsource firms in the Vancouver area.


Ultram patent:

Rating: 89 / 100

Overall: 93 Rates